Using SVM classifier, we regrouped HCC patients into two groups and Type A showed similar characteristics (clinical outcomes, CD8 T cell, T cell dysfunction and response to immunotherapy) with cluster1 in both TCGA cohort and external validation cohorts. The gene discussed is CD8A; the disease is hepatocellular carcinoma.